Many cancer treatments fail not because immune cells can’t recognize a tumor, but because the hostile environment surrounding it can prevent them from doing their job. Dyve Biosciences is seeking to address that problem by targeting tumor acidity, which the company says can suppress T-cell activity, promote immune evasion, and contribute to resistance to checkpoint inhibitors and other therapies. Its solution is a transdermal drug-delivery platform designed to move a buffering agent through the skin

In this episode of Behind the Genes, we explore Black communities and health research. Our guests discuss why some people feel research is not intended for them, how historical mistrust affects participation, and what needs to change to make research more inclusive, transparent and beneficial for everyone. Our host, Sharon Jones, is joined by: Professor Segun Fatumo - Professor and Chair of Genomic Diversity at Queen Mary's Hospital Christella Matoko - Project manager at Genomics

Key developments from Johnson & Johnson, Ultragenyx, Abogen Biosciences, and Daiichi Sankyo.

Better Patient Centricity by Adoption of Emerging Technologies What if healthcare could move beyond simply treating illness after it appears—and instead continuously help people predict, prevent, and manage their health? In this episode of Center of Excellence - Pharma 4.0, we explore how emerging technologies are transforming healthcare from a predominantly reactive, episodic model into a proactive, personalised, connected, and patient-centric ecosystem. The traditional healthcare experience often

It’s horror movie night, but Heather can’t stop seeing infectious disease in the monsters.Heather is joined by her friend Valerie to explore the real biology behind some of horror’s most enduring fears: tuberculosis and vampire lore, rabies and werewolves, zombies as outbreak epidemiology, neurological disease and possession, and the strange biology behind The Last of Us, The Thing, and Alien. Plus, Valerie plays the hilarious Horror Movie or Medical Literature? and discovers that when it comes to

Extinction requires far more than protecting habitat alone.

March of Dimes Ohio Collaborative Prematurity Research Center coordinating principal investigator and Cincinnati Children’s Hospital infectious disease pediatrician Dr. Sing Sing Way discusses his team's new findings linking the use of mouthwash in pregnancy with dramatically reduced rates of preeclampsia, preterm birth, and chorioamnionitis.

This week we discuss a bright orange toxic gummy lizard — we do not advise consumption of this salamander.

Clinical traceability is about being able to follow evidence from a reported result back to its source and understand the transformations, decisions, and records in between. In this QCast episode, co-hosts Jullia and Tom discuss how traceability can become harder when studies involve multiple systems, CROs, laboratories, and technology providers, and why retaining files alone is not enough.Key TakeawaysStrong traceability connects reported results with the underlying data, derivations, programs, and

Send us Fan MailProstate cancer: PSA, ADT, Gleason and Pluvicto explained live by a cancer drug designer. LIVE was filmed on 9/14/26. 👉 Get your free guide, '10 Things to Elevate Your Chemo Journey'👉 Want personalized attention to help you along your individual cancer journey? Explore 1:1 sessions with Dr. Chaplin👉 Want to find out more about Dr. Chaplin's journey of bringing a cancer drug to market? Explore his innovations--------------------------------------------Episode

In this episode of the Biohacker's Podcast, Teemu Arina speaks with Don Diablo on fear as fuel, discipline, fasting and building a creative legacy.Check https://hololifesummit.com for upcoming events & tickets.Devices, supplements, guides, books & quality online courses for supporting your health & performance: https://hololifecenter.comDon Diablo, DJ, producer, artist and founder of HEXAGONDon Diablo is a Dutch DJ, producer and multidisciplinary artist who released his first record

For decades, scientists pursued one goal: a vaccine that could prevent the disease. But malaria is caused by a complex parasite, making vaccine development far more challenging than for most infectious diseases. One scientist dedicated his career to this challenge. Sir Adrian Hill of the University of Oxford witnessed children dying from malaria in Gambia in the late 1980s and set out to develop a vaccine that could save lives where it was needed most. For this work, he received the European

Each week, join Editor-in-Chief Brad Maron, along with cohosts Mercedes Carnethon and Jane Wilcox for the new iteration of Circulation on the Run. This week, Brad and Jane welcome author Alexis F. Guédon to discuss his article "Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis." Then Deputy Editor Joseph C. Wu joins the podcast to discuss his Research Letter "Modeling Heart Failure With Preserved Ejection Fraction Using Human Induced

We can learn about horticulture from slides in a classroom, sure. But everything changes when the classroom is perhaps Rome, or the lab is a botanic garden in Scotland, and the homework might be noticing what’s growing on the hills and valleys outside the bus window. In this episode, our co-host, Curt Rom, talks with Co-Host Samson Humphrey about the value of studying abroad and how it can make the world feel bigger and smaller at the same time - something that Curt has learned not only from ...

New U.S. guidance carves out tariff exemptions for specialty pharmaceuticals, Pharming's Fabrice Chouraqui steps down as CEO amid a board rift, and a dealmaking roundup covers Hengrui Pharma's licensing agreement with Novo Nordisk and AstraZeneca's investment in Summit Therapeutics.

Paul and Trudi Schaefer always assumed they would live out their lives on the farm they built up over several decades. When they realized they needed to move on, their first step was to take LSP’s Farm Transition Planning Course. More Information • LSP 2027 Farm Transition Course • LSP Land Transition Tools • LSP…  Read More →Source

Today Razib talks to Kyle Orton. Orton is a freelance researcher, writer, and editor specializing in security and foreign policy, with a particular focus on the Middle East, the Syrian war, regional geopolitics, and terrorist movements including the Islamic State (ISIS), Iran's Islamic Revolutionary Guards Corps (IRGC), and the Kurdistan Workers' Party (PKK). His work also ranges widely across history, including early Christianity, Islam and its relationship with the West, intelligence and

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comCurranz Supplement: Use code MIKKIPEDIA to get 20% off your first order - go to www.curranz.co.nz  or www.curranz.co.uk to order yours NZ listeners - save 10% off Calocurb by using the code Mikkipedia10 at www.calocurb.co.nzEpisode SummaryCliff Harvey PhD is back on the podcast, and this one ranges widely before settling on its main subject. Cliff is a registered

Following the Mastering Ankle Instability & Sports Reconstruction session at the 2026 Foot Innovate Leadership Conference, moderator Bryan D. Den Hartog, MD, sits down with faculty Brian Burgess, DPM, FACFAS; James Cottom, DPM, FACFAS; Christopher D. Murawski, MD; and Justin Rennard, MD for a practical discussion on the evolving treatment of ankle instability and sports-related foot and ankle injuries. The faculty share their approaches to osteochondral lesions of the talus, including lesion size,